These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 1291662

  • 21. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease.
    Brenner BM, Meyer TW, Hostetter TH.
    N Engl J Med; 1982 Sep 09; 307(11):652-9. PubMed ID: 7050706
    [No Abstract] [Full Text] [Related]

  • 22. Angiotensin converting enzyme inhibitors and progression of chronic renal failure.
    Tolins JP, Raij L.
    Kidney Int Suppl; 1990 Nov 09; 30():S118-22. PubMed ID: 2259070
    [Abstract] [Full Text] [Related]

  • 23. Renal function changes in diabetes.
    Mogensen CE.
    Diabetes; 1976 Nov 09; 25(2 SUPPL):872-9. PubMed ID: 971791
    [Abstract] [Full Text] [Related]

  • 24. Modern antihypertensive treatment and the progression of renal disease.
    Bauer JH.
    J Hypertens Suppl; 1998 Oct 09; 16(5):S17-24. PubMed ID: 9869000
    [Abstract] [Full Text] [Related]

  • 25. Do glomerular hemodynamic adaptations influence the progression of human renal disease?
    Woolf AS, Fine LG.
    Pediatr Nephrol; 1991 Jan 09; 5(1):88-93. PubMed ID: 2025546
    [Abstract] [Full Text] [Related]

  • 26. Antihypertensive therapy in diabetes.
    Hostetter TH.
    Am J Kidney Dis; 1989 Jun 09; 13(6 Suppl 1):13-6. PubMed ID: 2735323
    [Abstract] [Full Text] [Related]

  • 27. Strategies to slow the progression of renal disease.
    Neuringer JR, Levey AS.
    Semin Nephrol; 1994 May 09; 14(3):261-73. PubMed ID: 8036361
    [Abstract] [Full Text] [Related]

  • 28. Risk factors for renal injury in children with a solitary functioning kidney.
    Westland R, Kurvers RA, van Wijk JA, Schreuder MF.
    Pediatrics; 2013 Feb 09; 131(2):e478-85. PubMed ID: 23319536
    [Abstract] [Full Text] [Related]

  • 29. Antihypertensive therapy and mobilization of renal functional reserve.
    Burnier M, Biollaz J, Steinhauslin F, Brouard R, Waeber B, Brunner HR.
    Clin Invest Med; 1991 Dec 09; 14(6):581-9. PubMed ID: 1686579
    [Abstract] [Full Text] [Related]

  • 30. [Arterial hypertension and diabetic nephropathy].
    Chaignon M, Guedon J.
    J Mal Vasc; 1992 Dec 09; 17(4):311-4. PubMed ID: 1494060
    [Abstract] [Full Text] [Related]

  • 31. [Glomerular-capillary hypertension. Experimental findings and their clinical importance].
    Anderson S, Brenner BM.
    Dtsch Med Wochenschr; 1988 Oct 07; 113(40):1543-5. PubMed ID: 3048961
    [No Abstract] [Full Text] [Related]

  • 32. Protein restriction, glomerular filtration rate and albuminuria in patients with type 2 diabetes mellitus: a randomized trial.
    Pijls LT, de Vries H, van Eijk JT, Donker AJ.
    Eur J Clin Nutr; 2002 Dec 07; 56(12):1200-7. PubMed ID: 12494305
    [Abstract] [Full Text] [Related]

  • 33. Treatment of hypertension in renal disease.
    Baldwin DS, Neugarten J.
    Am J Kidney Dis; 1985 Apr 07; 5(4):A57-70. PubMed ID: 3887904
    [Abstract] [Full Text] [Related]

  • 34. Hypertension and renal diseases.
    Baldwin DS, Neugarten J.
    Am J Kidney Dis; 1987 Sep 07; 10(3):186-91. PubMed ID: 3307395
    [Abstract] [Full Text] [Related]

  • 35. Consequences of Glomerular Hyperfiltration: The Role of Physical Forces in the Pathogenesis of Chronic Kidney Disease in Diabetes and Obesity.
    Chagnac A, Zingerman B, Rozen-Zvi B, Herman-Edelstein M.
    Nephron; 2019 Sep 07; 143(1):38-42. PubMed ID: 30947190
    [Abstract] [Full Text] [Related]

  • 36. Influence of antihypertensive therapy on development and progression of diabetic glomerulopathy.
    Anderson S, Brenner BM.
    Diabetes Care; 1988 Sep 07; 11(10):846-9. PubMed ID: 2977586
    [Abstract] [Full Text] [Related]

  • 37. Glomerular hyperfiltration: definitions, mechanisms and clinical implications.
    Helal I, Fick-Brosnahan GM, Reed-Gitomer B, Schrier RW.
    Nat Rev Nephrol; 2012 Feb 21; 8(5):293-300. PubMed ID: 22349487
    [Abstract] [Full Text] [Related]

  • 38. Therapeutic benefit of converting-enzyme inhibition in progressive renal disease.
    Anderson S, Brenner BM.
    Am J Hypertens; 1988 Oct 21; 1(4 Pt 2):380S-383S. PubMed ID: 3056448
    [Abstract] [Full Text] [Related]

  • 39. Pathophysiology and management of progressive renal disease.
    Brown SA, Crowell WA, Brown CA, Barsanti JA, Finco DR.
    Vet J; 1997 Sep 21; 154(2):93-109. PubMed ID: 9308397
    [Abstract] [Full Text] [Related]

  • 40. Preventive approach to diabetic kidney disease.
    Viberti G, Bending JJ.
    Contrib Nephrol; 1988 Sep 21; 61():91-100. PubMed ID: 3282790
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.